UBIQUITIN/PROTEASOME INHIBITORS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY.

• 1. 用于治疗脊髓性肌肉萎缩症的组合物和方法 [P] . 中国专利： CN109475625A . 2019-03-15
• 2. 用于治疗肌肉萎缩症患者的寡核苷酸 [P] . 中国专利： CN104603271B . 2019.07.19
• 3. Ubiquitin / proteasome inhibitors for the treatment of spinal muscular atrophy [P] . 日本专利： JP2009526854A . 2009-07-23

  机译： 泛素/蛋白酶体抑制剂治疗脊髓性肌萎缩

• 4. UBIQUITIN/PROTEASOME INHIBITORS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY [P] . 欧洲知识产权局专利： EP1983828A2 . 2008-10-29

  机译： 用于治疗脊髓肌萎缩症的泛肽/药物抑制剂

• 5. UBIQUITIN/PROTEASOME INHIBITORS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY [P] . 世界知识产权组织专利： WO2007097980A3 . 2007-12-13

  机译： 用于治疗脊髓肌萎缩症的泛肽/药物抑制剂

• 1. Large deletions within the spinal muscular atrophy gene region in a patient with spinal muscular atrophy type 3 [J] . Wei Wei, Chunyue Chen, Wenting Liu, 中国神经再生研究（英文版） . 2011,第023期
• 2. Large deletions within the spinal muscular atrophy gene region in a patient with spinal muscular atrophy type [J] . Wei Wei, Chunyue Chen, Wenting Liu, 中国神经再生研究：英文版 . 2011,第023期
• 3. Cell cycle and complement inhibitors may be specific for treatment of spinal cord injury in aged and young mice:transcriptomic analyses [J] . Ming Hao, Xin-ran Ji, Hua Chen, 中国神经再生研究（英文版） . 2018,第003期
• 4. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. [J] . Hahnen E, Eyupoglu IY, Brichta L, Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry . 2006,第1期
• 5. Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. [J] . Rusmini P, Sau D, Crippa V, Neurobiology of Aging: Experimental and Clinical Research . 2007,第7期
• 6. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. [J] . Iannaccone ST, Russman BS, Browne RH, Journal of child neurology . 2000,第2期
• 7. Dihydroeponemycin inhibits ubiquitin proteasome system of Plasmodium falciparum in silico [C] . K Mardhiyyah, M H Arif, L E Fitri, International Seminar on Smart Molecule of Natural Resources . 2020
• 8. Optimization of a series of Isoxazoles for the treatment of Spinal Muscular Atrophy. [D] . Kern, Nicholas Louis. 2016
• 9. Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System [O] . Q. Ping Dou, Jeffrey A. Zonder -1
• 10. Neuroprotective effect of non-viral gene therapy treatment based on tetanus toxin C-fragment in a severe mouse model of Spinal Muscular Atrophy. [O] . Sara Olivan Garcia, Ana Cristina Calvo, Amaya Rando, 2016

• 1. Proteasome inhibitor treatment in alcoholic liver disease [J] . Fawzia Bardag-Gorce . 世界胃肠病学杂志：英文版 . 2011,第20期
• 2. 26S proteasome inhibitors inhibit dexamethasone-dependent increase of tyrosine aminotransferase and tryptophan 2,3-dioxygenase mRNA levels in primary cultured rat hepatocytes [J] . Mizuho Harashima ,Masashi Hyuga ,Youko Nagaoka . 生物物理化学（英文） . 2012,第4期
• 3. 基于质谱的蛋白质组学应用于大鼠急性脊髓损伤及其电针治疗的研究 [C] . 杨松成 ,王鸿丽 ,韩静 . 第十五届全国有机分析及生物分析学术研讨会 . 2009
• 4. 可注射导电水凝胶的构建及其用于治疗脊髓损伤的研究 [A] . 罗义安 . 2020